Adapthealth (AHCO) insider buying
5 open-market purchases of AHCO by Adapthealth's executives and directors since March 2026, worth $24M in total, from SEC Form 4 filings.
The most recent: Richard M Cashin Jr bought $4M on March 20, 2026.
The biggest buyer over the period is Richard M Cashin Jr: 5 purchases, $24M.
By year
| Year | Purchases | Value |
|---|---|---|
| 2026 | 5 | $24M |
Biggest buyers
| Insider | Buys | Value |
|---|---|---|
| Richard M Cashin Jr | 5 | $24M |
Every purchase
Newest first. From SEC Form 4 filings. Insider buying across the market.
| Date | Insider | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Mar 20, 2026 | Richard M Cashin Jr |
447,100 | $9.91 | $4M | Form 4 |
| Mar 19, 2026 | Richard M Cashin Jr |
727 | $9.94 | $7,226 | Form 4 |
| Mar 12, 2026 | Richard M Cashin Jr |
689,336 | $9.73 | $7M | Form 4 |
| Mar 11, 2026 | Richard M Cashin Jr |
536,827 | $9.73 | $5M | Form 4 |
| Mar 10, 2026 | Richard M Cashin Jr |
820,528 | $9.73 | $8M | Form 4 |
Questions
Are Adapthealth insiders buying the stock?
5 open-market purchases of AHCO by Adapthealth's executives and directors since March 2026, worth $24M in total, from SEC Form 4 filings. The most recent: Richard M Cashin Jr bought $4M on March 20, 2026.
What counts as insider buying here?
Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.
From Adapthealth's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.